Environment &
Food & Beverage
Cosmetics
Life Sciences
Metal & Mining Industry
Petrochemical & General Chemistry
Automotive Related & Interior Materials
Applications including "InertSustain C18"
-
LT207 - Anaysis of Antioxidant capacity by post-column HPLC using DPPH radical -
LC Technical Note InertSustain C18 -
LT204 - Validity evaluation of methidathione oxone in tap water using LC-MS/MS -
LC Technical Note InertSustain C18 -
LT203 - Analysis of cyclosporin A in serum using MonoSpin C18 and Ph. -
LC Technical Note InertSustain Phenyl -
LT201 - Analysis of nitrosoamines by LC-MS / MS, HPLC using InertSustain AQ-C18 -Comparison with PFP column- -
LC Technical Note InertSustain AQ-C18 InertSustain PFP -
LT200 - InertSustain & Inertsil HPLC Columns for Reversed Phase Separation -
LC Technical Note InertSustain C18 InertSustain AQ-C18 InertSustainSwift C18 InertSustain AX-C18 Inertsil ODS-HL Inertsil ODS-4 Inertsil ODS-3 Inertsil ODS-P Inertsil ODS-EP InertSustain C8 Inertsil C8-4 Inertsil C4 Inertsil WP300 C18 Inertsil WP300 C8 Inertsil WP300 C4 InertSustain PFP InertSustain Phenyl InertSustain Phenylhexyl -
LT197 - Analysis of capsaicin by HPLC and LC/MS/MS -
LC Technical Note InertSustain C18 -
LT195 - Eighteenth revision Japanese Pharmacopoeia analysis of tranexamic acid -2.00 Condition change within the range specified in the general chromatography- -
LC Technical Note InertSustain AQ-C18 -
ST030 - Analysis of cyromazine in livestock products -
SPE Technical Note InertSustain C18 -
ST029 - Analysis of Kasugamycin -
SPE Technical Note InertSep C18 InertSustain Amide -
LB161 - Analysis of Clopidogrel sulfate (InertSustain C18) (Under the Condition of the Japanese Pharmacopoeia, Clopidogrel sulfate Tablets) -
LC InertSearch InertSustain C18 -
LB043 - Analysis of 18Drugs(InertSustain C18 HP) -
LC InertSearch InertSustain C18 -
LA974 - Analysis of Non-ionic surfactant(Detected by Pre-Column complexation with Co-PAR) -
LC InertSearch InertSustain C18 -
LA911 - Analysis of 16 kinds of Aldehydes(Detected by Pre-Column Method with DNPH) -
LC InertSearch InertSustain C18 -
LA908 - Analysis of 17 Anti-depressant drugs (InertSustain C18) -
LC InertSearch InertSustain C18 -
LA907 - Analysis of Water-soluble Vitamins (InertSustain C18) -
LC InertSearch InertSustain C18 -
LA901 - Analysis of linear fatty acids (InertSustain C18) -
LC InertSearch InertSustain C18 -
LA894 - Analysis of organic acids (InertSustain C18) -
LC InertSearch InertSustain C18 -
LB902 - Analysis of Saxagliptin -
LC InertSearch InertSustain C18 -
LB901 - Analysis of Saxagliptin -
LC InertSearch InertSustain C18 -
LB899 - Analysis of Fesoterodine Fumarate -
LC InertSearch InertSustainSwift C18 -
LB898 - Analysis of Benzoic acid, Sorbic acid and Dehydroacetic acid -
LC InertSearch InertSustain AQ-C18 -
LB896 - Analysis of Triptorelin Pamoate -
LC InertSearch InertSustain C18 -
LB892 - Analysis of Chlorophenols -
LC InertSearch InertSustain C18 HP -
LB891 - Analysis of Saxagliptin -
LC InertSearch InertSustain C18 HP -
LB890 - Analysis of Saxagliptin -
LC InertSearch InertSustain C18 HP -
LB886 - Analysis of Glyphosate,Mecoprop,Bromacil -
LC InertSearch InertSustain AX-C18 -
LB885 - Analysis of Voriconazole -
LC InertSearch InertSustain C18 -
LB884 - Analysis of Voriconazole -
LC InertSearch InertSustain C18 -
LB882 - Analysis of Paracetamol and Mefenamic acid -
LC InertSearch InertSustain C18 -
LB880 - Analysis of Paracetamol and Mefenamic acid -
LC InertSearch InertSustain C18 -
LB878 - Analysis of Mefenamic acid -
LC InertSearch InertSustain C18 -
LB876 - Analysis of Cefoxitin -
LC InertSearch InertSustain C18 -
LB874 - Analysis of Captopril and Captopril Disulfide -
LC InertSearch InertSustain AQ-C18 -
LB873 - Tacrolimus Extended-Release Capsules -
LC InertSearch InertSustain AQ-C18 -
LB868 - Analysis of Propionic Acid -
LC InertSearch InertSustain C18 -
LB867 - Analysis of Febuxostat -
LC InertSearch InertSustain C18 -
LB866 - Analysis of Sucralose -
LC InertSearch InertSustain C18 -
LB865 - Analysis of Water-soluble vitamins and D-Araboascorbic acid -
LC InertSearch InertSustain C18 -
LB864 - Analysis of Benzoic acid, Sorbic acid and Dehydroacetic acid -
LC InertSearch InertSustain C18 -
LB863 - Analysis of BHT_BHA_PG（Analytical Method A） -
LC InertSearch InertSustain C18 -
LB862 - Analysis of Antioxidants -
LC InertSearch InertSustain C18 -
LB860 - Analysis of Glycyrrhizinate acid -
LC InertSearch InertSustain C18 -
LB858 - Analysis of Natamycin (Analytical Method B) -
LC InertSearch InertSustain C18 -
LB857 - Analysis of Natamycin (Analytical Method A) -
LC InertSearch InertSustain AQ-C18 -
LB855 - Analysis of 6 kinds of Aldehydes (Detected by Pre-Column Method with DNPH) -
LC InertSearch InertSustain C30 -
LB854 - Analysis of Naringin and Hesperidin -
LC InertSearch InertSustain AQ-C18 -
LB853 - Analysis of p-Hydroxybenzoic acid esters -
LC InertSearch InertSustain C18 -
LB852 - Analysis of Benzoic acid -
LC InertSearch InertSustain C18 -
LB851 - Analysis of Calcium Pantothenate -
LC InertSearch InertSustain AQ-C18 -
LB850 - Analysis of Ethylenediaminetetraacetic acid ferric sodium salt trihydrate -
LC InertSearch InertSustain C18 -
LB846 - Analysis of Tocopheryl acetate -
LC InertSearch InertSustain C18 -
LB845 - Analysis of L-Ascorbyl palminate and L-Ascorbic Stearate -
LC InertSearch InertSustain C18 -
LB835 - Analysis of Sudan dyes and Para red -
LC InertSearch InertSustain C18 -
LB834 - Analysis of Paraoxybenzoic acid esters -
LC InertSearch InertSustain C18 -
LB833 - Analysis of Methyl Parahydroxybenzoate -
LC InertSearch InertSustain C18 -
LB832 - Analysis of Nordihydroguaiaretic Acid -
LC InertSearch InertSustain C18 -
LB831 - Analysis of Nordihydroguaiaretic Acid -
LC InertSearch InertSustain C18 -
LB830 - Analysis of Azoxystrobin -
LC InertSearch InertSustain C18 -
LB828 - Analysis of Chloroprocaine Hydrochloride -
LC InertSearch InertSustain C18 -
LB827 - Analysis of Clobetasone butyrate standard -
LC InertSearch InertSustainSwift C18 -
LB826 - Analysis of Nicotinic acid and Nicotinamide (Under the Condition of food additive analysis method in food) -
LC InertSearch InertSustain C18 -
LB824 - Analysis of kojic acid -
LC InertSearch InertSustain C18 -
LB819 - Analysis of ATP and Cyclic nucleotide (InertSustain AQ-C18) -
LC InertSearch InertSustain AQ-C18 -
LB818 - Analysis of Nucleotides and Cyclic nucleotides -
LC InertSearch InertSustain AX-C18 -
LB817 - Analysis of Phospholipids -
LC InertSearch InertSustainSwift C18 -
LB816 - Analysis of Zoledronic acid -
LC InertSearch InertSustainSwift C18 -
LB815 - Analysis of Riboflavin (Vitamin B2) and its metabolites -
LC InertSearch InertSustainSwift C18 -
LB814 - Analysis of Coenzyme A (CoA) -
LC InertSearch InertSustain AQ-C18 -
LB813 - Analysis of Fosetyl and Glyphosate -
LC InertSearch InertSustain AQ-C18 -
LB812 - Analysis of Dehydroacetic acid -
LC InertSearch InertSustain C18 -
LB809 - Analysis of ATP related compounds and Guanylic acid -
LC InertSearch InertSustain AQ-C18 -
LB805 - Analysis of nonvolatile amines (prelabel derivatization by Dansyl Chloride) -
LC InertSearch InertSustain C18 -
LB800 - Analysis of 1,3-Dicyclohexylurea -
LC InertSearch InertSustain C18 -
LB789 - Analysis of Oligonucleotides -
LC InertSearch InertSustain AX-C18 -
LB788 - Analysis of Oligonucleotides -
LC InertSearch InertSustain AX-C18 -
LB787 - Analysis of Oligonucleotides -
LC InertSearch InertSustain AX-C18 -
LB786 - Analysis of Oligonucleotides -
LC InertSearch InertSustain AX-C18 -
LB785 - Analysis of Uric Acid and its related compounds -
LC InertSearch InertSustain AX-C18 -
LB784 - Analysis of ATP and its related compounds -
LC InertSearch InertSustain AX-C18 -
LB783 - Analysis of UTP and its related compounds -
LC InertSearch InertSustain AX-C18 -
LB782 - Analysis of GTP and its related compounds -
LC InertSearch InertSustain AX-C18 -
LB781 - Analysis of CTP and its related compounds -
LC InertSearch InertSustain AX-C18 -
LB780 - Analysis of ATP and its related compounds -
LC InertSearch InertSustain AX-C18 -
LB779 - Analysis of Coenzyme A (CoA) -
LC InertSearch InertSustain AX-C18 -
LB778 - Analysis of Coenzyme A (CoA) -
LC InertSearch InertSustain AX-C18 -
LB777 - Analysis of Sugar Phosphates -
LC InertSearch InertSustain AX-C18 -
LB776 - Analysis of Sugar Phosphates -
LC InertSearch InertSustain AX-C18 -
LB775 - Analysis of Cyclic Nucleotide -
LC InertSearch InertSustain AX-C18 -
LB774 - Analysis of Nucleotide sugars -
LC InertSearch InertSustain AX-C18 -
LB773 - Analysis of Nicotinamide adenine dinucleotide and Nicotinamide adenine dinucleotide phosphate (NAD+, NADH, NADP+, NADPH) -
LC InertSearch InertSustain AX-C18 -
LB772 - Analysis of Nicotinamide adenine dinucleotide (NADH, NAD+) -
LC InertSearch InertSustain AX-C18 -
LB771 - Analysis of Nucleoside and Nucleic acid base -
LC InertSearch InertSustain AX-C18 -
LB770 - Analysis of Pyruvic acid and Phosphoenolpyruvic acid -
LC InertSearch InertSustain AX-C18 -
LB769 - Analysis of Thiamine and Thiamine pyrophosphate -
LC InertSearch InertSustain AX-C18 -
LB768 - Analysis of Low molecular weight Hyaluronic acid -
LC InertSearch InertSustain AX-C18 -
LB767 - Analysis of Chondroitin Sulfate -
LC InertSearch InertSustain AX-C18 -
LB766 - Analysis of Glucuronic acid -
LC InertSearch InertSustain AX-C18 -
LB765 - Analysis of Sialic acid -
LC InertSearch InertSustain AX-C18 -
LB764 - Analysis of Organic acids -
LC InertSearch InertSustain AX-C18 -
LB763 - Analysis of Tryptophan metabolites -
LC InertSearch InertSustain AX-C18 -
LB762 - Analysis of L-Cysteic acid -
LC InertSearch InertSustain AX-C18 -
LB760 - Analysis of Doripenem (Under the Condition of the Japanese Pharmacopoeia 18th, Doripenem Hydrate) -
LC InertSearch InertSustain C18 -
LB759 - Analysis of Doripenem (Under the Condition of the Japanese Pharmacopoeia 18th, Doripenem Hydrate) -
LC InertSearch InertSustain AX-C18 -
LB758 - Analysis of Doripenem (Under the Condition of the Japanese Pharmacopoeia 18th, Doripenem Hydrate) -
LC InertSearch InertSustain C18 -
LB755 - Analysis of Oxaliplatin (Under the Condition of the draft for the Japanese Pharmacopoeia18th supplement II) -
LC InertSearch InertSustainSwift C18 -
LB745 - Analysis of of Metformin Hydrochloride Tablets（Under the Condeition of USP43-NF38, Glyburide and Metformin Hydrochloride Tablets) -
LC InertSearch InertSustain C18 -
LB738 - Analysis of Remdesivir -
LC InertSearch InertSustain AX-C18 -
LB737 - Analysis of Favipiravir -
LC InertSearch InertSustain AX-C18 -
LB736 - Analysis of Antidepressants -
LC InertSearch InertSustain AX-C18 -
LB735 - Analysis of Antihistamines -
LC InertSearch InertSustain AX-C18 -
LB734 - Analysis of components of coffee -
LC InertSearch InertSustain AX-C18 -
LB733 - Analysis of Water-soluble Vitamins -
LC InertSearch InertSustain AX-C18 -
LB732 - Analysis of Peptides -
LC InertSearch InertSustain AX-C18 -
LB731 - Analysis of Peptides -
LC InertSearch InertSustain AX-C18 -
LB730 - Analysis of Glutathione -
LC InertSearch InertSustain AX-C18 -
LB729 - Analysis of L-Cystine and L-Cysteine and L-Cysteic acid -
LC InertSearch InertSustain AX-C18 -
LB728 - Analysis of Taurine (2-Aminoethanesulfonic acid) -
LC InertSearch InertSustain AX-C18 -
LB727 - Analysis of Aspartic acid and Glutamic acid -
LC InertSearch InertSustain AX-C18 -
LB726 - Analysis of Carbocisteine -
LC InertSearch InertSustain AX-C18 -
LB725 - Analysis of Glyceric acid -
LC InertSearch InertSustain AX-C18 -
LB724 - Analysis of Glyphosate and Glufosinate -
LC InertSearch InertSustain AX-C18 -
LB723 - Analysis of Insulin Chain B Oxidized -
LC InertSearch InertSustain AX-C18 -
LB722 - Analysis of Ethenzamide -
LC InertSearch InertSustain C18 -
LB721 - Analysis of Acetaminophen -
LC InertSearch InertSustain C18 -
LB720 - Analysis of Acetylsalicilic acid -
LC InertSearch InertSustain C18 -
LB716 - Analysis of Toluene and Toluene d8 -
LC InertSearch InertSustain C18 -
LB715 - Analysis of Toluene and Toluene d8 -
LC InertSearch InertSustainSwift C18 -
LB711 - Analysis of Underivatized Glyphosate, Glufosinate and Other Polar Pesticides -
LC InertSearch InertSustain AX-C18 -
LB710 - Analysis of Per - and Polyfluoroalkyl Substances (PFAS) -
LC InertSearch InertSustain C18 HP -
LB709 - Analysis of Per - and Polyfluoroalkyl Substances (PFAS) -
LC InertSearch InertSustain AQ-C18 -
LB708 - Analysis of Per - and Polyfluoroalkyl Substances (PFAS) -
LC InertSearch InertSustain AQ-C18 -
LB707 - Analysis of Per - and Polyfluoroalkyl Substances (PFAS) -
LC InertSearch InertSustain AQ-C18 -
LB706 - Analysis of Per - and Polyfluoroalkyl Substances (PFAS) -
LC InertSearch InertSustain AQ-C18 -
LB705 - Analysis of Per - and Polyfluoroalkyl Substances (PFAS) -
LC InertSearch InertSustain AQ-C18 -
LB704 - Analysis of Phosphate ester flame retardants (PFRs) -
LC InertSearch InertSustainSwift C18 -
LB703 - Analysis of Phosphate ester flame retardants (PFRs) -
LC InertSearch InertSustainSwift C18 -
LL038 - Analysis of cannabinoids -
LC InertSearch InertSustainSwift C18 -
LL037 - Analysis of cannabinoids -
LC InertSearch InertSustain C18 -
LB702 - Analysis of ibuprofen -
LC InertSearch InertSustain C18 -
LB700 - Analysis of acetaminophen -
LC InertSearch InertSustain C18 -
LB698 - Analysis of Neomycin Sulfate (European Pharmacopoeia 11.0th Edition, Purity Test) -
LC InertSearch InertSustain C18 -
LB696 - Analysis of Trifluoroacetic acid -
LC InertSearch InertSustain AQ-C18 -
LB695 - Analysis of acetic acid （USP） -
LC InertSearch InertSustainSwift C18 -
LB692 - Analysis of Nitrosamines -
LC InertSearch InertSustain AQ-C18 -
LB689 - Analysis of Capsaicin in red pepper (InertSustain AQ-C18) -
LC InertSearch InertSustain AQ-C18 -
LB688 - Analysis of Red pepper extract -
LC InertSearch InertSustain C18 -
LB686 - Analysis of Chlorogenic acid -
LC InertSearch InertSustain AX-C18 -
LB682 - Analysis of Acetic acid and Acetic anhydride -
LC InertSearch InertSustainSwift C18 -
LB680 - Analysis of bromate -
LC InertSearch InertSustain C18 -
LB679 - Analysis of Cetylpyridinium chloride -
LC InertSearch InertSustain AX-C18 -
LB678 - Analysis of Validamycin -
LC InertSearch InertSustain C18 HP -
LB677 - Analysis of Zebularine and Gemcitabine -
LC InertSearch InertSustain C18 HP -
LB673 - Analysis of Limonene -
LC InertSearch InertSustain C18 -
LB669 - Analysis of Rosuvastatin calcium (Under the condition of the Japanese Pharmacopoeia (JP) ) -
LC InertSearch InertSustainSwift C18 -
LL033 - Analysis of Phospholipids -
LC InertSearch InertSustain C18 -
LB656 - Analysis of Peptides -
LC InertSearch InertSustain AQ-C18 -
LB655 - Analysis of Peptides -
LC InertSearch InertSustain C18 -
LB641 - Analysis of Rosuvastatin Calcium (Under the Condition of draft for Japanese Pharmacopoeia, Rosuvastatin Calcium) -
LC InertSearch InertSustain C18 -
LB640 - Analysis of Rosuvastatin Calcium (Under the Condition of draft for Japanese Pharmacopoeia, Rosuvastatin Calcium) -
LC InertSearch InertSustain C18 -
LB639 - Analysis of Levetiracetam (Under the Condition of USP42-NF37 1S, Levetiracetam Oral Solution) -
LC InertSearch InertSustainSwift C18 -
LB638 - Analysis of Levetiracetam (Under the Condition of USP42-NF37 1S, Levetiracetam Oral Solution) -
LC InertSearch InertSustain C18 -
LB636 - Analysis of Levetiracetam (Under the Condition of USP42-NF37 1S, Levetiracetam Tablets) -
LC InertSearch InertSustainSwift C18 -
LB635 - Analysis of Levetiracetam (Under the Condition of draft for USP) -
LC InertSearch InertSustain AQ-C18 HP -
LB634 - Analysis of Rivaroxaban (Under the Condition of draft for USP, Rivaroxaban Tablets) -
LC InertSearch InertSustainSwift C18 -
LB633 - Analysis of Rivaroxaban (Under the Condition of draft for USP) -
LC InertSearch InertSustainSwift C18 -
LB626 - Analysis of Prasugrel hydrochloride -
LC InertSearch InertSustain C18 -
LB625 - Analysis of Prasugrel hydrochloride (Under the Condition of USP42-NF37) -
LC InertSearch InertSustainSwift C18 -
LB621 - Analysis of Venlafaxine hydrochloride (Under the Condition of USP41-NF36, Venlafaxine Hydrochloride Extended-Release Capsules) -
LC InertSearch InertSustain C18 -
LB620 - Analysis of Venlafaxine hydrochloride (Under the Condition of USP41-NF36, Venlafaxine Tablets) -
LC InertSearch InertSustain C18 -
LB619 - Analysis of Venlafaxine hydrochloride (Under the Condition of USP41-NF36, Venlafaxine Hydrochloride) -
LC InertSearch InertSustain C8 -
LB618 - Analysis of Pregabalin (Under the Condition of USP41-NF36, Pregabalin) -
LC InertSearch Inertsil ODS-3 -
LB613 - Analysis of Isopropylmethylphenol -
LC InertSearch InertSustain AQ-C18 -
LT168 - Simultaneous analysis of pesticides in tap water using LC-MS/MS -
LC Technical Note InertSustain C18 HP InertSustain C18 Guard Column for UHPLC -
LT166 - Simultaneous Analysis of 12 Soybean Isoflavones -
LC Technical Note InertSustainSwift C18 -
LT163 - Analysis of UV Absorbers in Cosmetic Products -
LC Technical Note InertSustain C18 -
LT161 - Purification of Ribavirin in Human Serum Using MonoSpin PBA -
LC Technical Note InertSustain AQ‐C18 HP -
LT159 - Assay Test for Esomeprazole Magnesium Delayed -Release Capsules under USP Method -
LC Technical Note InertSustain C18 -
LT157 - Examination of Loading Capacity of Proteins Using MonoSpin C18 -
LC Technical Note InertSustainBio C18 -
LT156 - Sample Preparation of Peptides and Proteins Using MonoSpin C18 -Obtain High Recovery with Ethanol Elution- -
LC Technical Note InertSustainBio C18 -
LT155 - Metal-free Columns for HPLC Part2 -
LC Technical Note InertSustain C18 PEEK Column -
LT152 - Metal-free Columns for HPLC Part 1 -
LC Technical Note InertSustainSwift C18 InertSustain C18 PEEK Column -
LT135 - Simultaneous Analysis of Tap Water Pesticides by LC/MS/MS -
LC Technical Note InertSustain C18 -
LT130 - Analysis of Anion Surfactants by LC/MS/MS -
LC Technical Note InertSustain C18 HP Inertsil C8-4 HP -
LT124 - Analysis of Furfural in Insulating Oil -
LC Technical Note InertSustainSwift C18 InertSustain AQ-C18 -
LT108 - Simultaneous Analysis of Organic Fluorine Compounds Using LC/MS/MS -
LC Technical Note InertSustain C18 -
LT107 - Simultaneous LC/MS/MS Analysis of Pesticides Used in Golf Courses -
LC Technical Note InertSustain C18 -
LT100 - Inertsil HPLC Columns for Reversed Phase Separation (2) -
LC Technical Note InertSustain C18 Inertsil ODS-4 Inertsil ODS-3 Inertsil ODS-2 Inertsil ODS-SP Inertsil ODS-EP Inertsil ODS-P Inertsil WP300 C18 InertSustain C8 Inertsil C8-3 Inertsil C8-4 Inertsil WP300 C8 InertSustain Phenyl Inertsil Ph-3 Inertsil Ph -
LT099 - Analysis of Valsartan -
LC Technical Note InertSustain C18 -
LT092 - Analysis of Tranexamic Acid According to the Japanese Pharmacopoeia -
LC Technical Note InertSustain AQ-C18 Inertsil ODS-4 -
LL030 - Simultaneous analysis of bile acids using LCMSMS -
LC InertSearch InertSustain C18 -
LL029 - Simultaneous analysis of lipid mediators using LC/MS/MS -
LC InertSearch InertSustain C18 -
LL027 - Analysis of Isothiazolinone preservatives -
LC InertSearch InertSustain AQ-C18 -
LL023 - Analysis of Triclosan -
LC InertSearch InertSustain C18 -
LL022 - Analysis of Catechins (InertSustain C18) -
LC InertSearch InertSustain C18 -
LL019 - Analysis of Food Colorants (InertSustainSwift C18) -
LC InertSearch InertSustainSwift C18 -
LL017 - Analysis of Food Colorants (InertSustain C18) -
LC InertSearch InertSustain C18 -
LL015 - Simultaneous analysis of metabolites using LCMSMS (5) - compounds related to central metabolism part 2 - -
LC InertSearch InertSustain C18 -
LL014 - Simultaneous analysis of metabolites using LCMSMS (4) - compounds related to central metabolism part 1 - -
LC InertSearch InertSustain C18 -
LL013 - Simultaneous analysis of metabolites using LC/MS/MS (3) - nucleobases and their related compounds part 2 - -
LC InertSearch InertSustain C18 -
LL012 - Simultaneous analysis of metabolites using LC/MS/MS (2) - nucleobases and their related compounds part 1 - -
LC InertSearch InertSustain C18 -
LL011 - Simultaneous analysis of metabolites using LC/MS/MS (1) - amino acids and their related compounds - -
LC InertSearch InertSustain C18 -
LB568 - Analysis of Steviol glycosides (Under the Condition of the JSFA-IX (Japanese Standards of Food Additives), Steviol Glycosides) -
LC InertSearch InertSustain AQ-C18 -
LB566 - Analysis of Steviol glycosides (Under the Condition of the JSFA-IX (Japanese Standards of Food Additives), Stevia Extract) -
LC InertSearch InertSustain AQ-C18 -
LB563 - Analysis of Steviol (Under the Condition of the JPE (Japanese Pharmaceutical Excipients), Purified Stevia Extract (4) Steviol) -
LC InertSearch InertSustain AQ-C18 -
LB561 - Analysis of Neotame (Under the Condition of the JSFA-IX (Japanese Standards of Food Additives)) -
LC InertSearch InertSustain AQ-C18 -
LB560 - Analysis of Advantame (Under the Condition of the JSFA-IX (Japanese Standards of Food Additives)) -
LC InertSearch InertSustain AQ-C18 -
LB559 - Analysis of Artificial sweeteners -
LC InertSearch InertSustain AQ-C18 -
LB556 - Analysis of Mirtazapine -
LC InertSearch InertSustain C18 -
LB554 - Analysis of Mirtazapine (Under the Condition of USP41-NF36, Mirtazapine Orally Disintegrating Tablets) -
LC InertSearch InertSustainSwift C18 -
LB553 - Analysis of Mirtazapine (Under the Condition of USP41-NF36, Mirtazapine Tablets) -
LC InertSearch InertSustain C18 -
LB552 - Analysis of Mirtazapine (Under the Condition of USP41-NF36, Mirtazapine) -
LC InertSearch InertSustain C18 -
LB551 - Analysis of Ezetimibe (Under the Condition of USP41-NF36, Ezetimibe Tablets) -
LC InertSearch InertSustainSwift C18 -
LB550 - Analysis of Ezetimibe (Under the Condition of USP41-NF36, Ezetimibe Tablets) -
LC InertSearch InertSustainSwift C18 -
LB548 - Analysis of Sitagliptin (Under the Condition of draft for USP, Sitagliptin and Metformin Hydrochloride Tablets) -
LC InertSearch InertSustain C18 -
LB547 - Analysis of Sitagliptin (Under the Condition of draft for USP, Sitagliptin and Metformin Hydrochloride Tablets) -
LC InertSearch InertSustain C18 -
LB546 - Analysis of Cinacalcet Hydrochloride (Under the Condition of draft for USP) -
LC InertSearch InertSustainSwift C18 -
LB545 - Analysis of Cinacalcet Hydrochloride (Under the Condition of draft for USP) -
LC InertSearch InertSustainSwift C18 -
LB544 - Analysis of Catecholamines -
LC InertSearch InertSustain AQ-C18 -
LB536 - Analysis of Telmisartan and Hydrochlorothiazide (Under the Condition of USP41-NF36, Telmisartan and Hydrochlorothiazide Tablets) -
LC InertSearch InertSustain C18 -
LB532 - Analysis of Sodium Valproate (Under the Condition of the draft for the Japanese Pharmacopoeia, Sodium Valproate Extended-release Tablets B) -
LC InertSearch InertSustain C18 -
LB531 - Analysis of Sodium Valproate (Under the Condition of the draft for the Japanese Pharmacopoeia, Sodium Valproate Extended-release Tablets A) -
LC InertSearch InertSustain C18 -
LB529 - Analysis of Carnosine (Under the Condition of the draft for the Japanese Pharmacopoeia, Poraprezinc Granules) -
LC InertSearch InertSustain C18 -
LB528 - Analysis of Carnosine (Under the Condition of the draft for the Japanese Pharmacopoeia, Poraprezinc) -
LC InertSearch InertSustain C18 -
LB522 - Analysis of Glutathione and its related compounds -
LC InertSearch InertSustain AQ-C18 -
LB521 - Analysis of Folic acid -
LC InertSearch InertSustain C18 -
LB520 - Analysis of Valsartan and Hydrochlorothiazide(Under the Condition of the draft for the Japanese Pharmacopoeia, Valsartan and Hydrochlorothiazide Tablets) -
LC InertSearch InertSustain C18 -
LB519 - Analysis of Valsartan and Hydrochlorothiazide(Under the Condition of the draft for the Japanese Pharmacopoeia, Valsartan and Hydrochlorothiazide Tablets) -
LC InertSearch InertSustainSwift C18 -
LB518 - Analysis of Glycyrrhetinic acid (Under the Condition of the Japanese Standards of Quasi-drug Ingredients, Monoammonium α-Glycyrrhizinate) -
LC InertSearch InertSustain C18 -
LB517 - Analysis of Glycyrrhizic acid (Under the Condition of the Japanese Standards of Quasi-drug Ingredients, Glycyrrhiza Extracted Powder) -
LC InertSearch InertSustain C18 -
LB516 - (Under the Condition of the Japanese Standards of Quasi-drug Ingredients, Coffee Extract) -
LC InertSearch InertSustain C18 -
LB515 - Analysis of Caffeine (Under the Condition of the Japanese Standards of Quasi-drug Ingredients, Coffee Extract) -
LC InertSearch InertSustain C18 -
LB514 - Analysis of Oligonucleotides -
LC InertSearch InertSustainSwift C18 -
LB513 - Analysis of Peptide hormones -
LC InertSearch InertSustainBio C18 -
LB512 - Analysis of Pioglitazone hydrochloride （Under the Condition of the draft for USP） -
LC InertSearch InertSustain C18 -
LB511 - Analysis of Parabens, Estradiol and Progesterone -
LC InertSearch InertSustainSwift C18 -
LB510 - Analysis of Estradiol and Progesterone (Under the Condition of the draft for the Japanese Standards of Quasi-drug Ingredients, Placental Extract) -
LC InertSearch InertSustainSwift C18 -
LB509 - Analysis of Angiotensin -
LC InertSearch InertSustainBio C18 -
LB507 - Analysis of Fatty acids by LC/MS/MS -
LC InertSearch InertSustain AQ-C18 -
LB506 - Analysis of Neonicotinoids -
LC InertSearch InertSustain C18 -
LB504 - Analysis of Fipronil -
LC InertSearch InertSustainSwift C18 -
LB489 - Analysis of Azosemide (Under the Condition of the draft for the Japanese Pharmacopoeia, Azosemide Tablets) -
LC InertSearch InertSustain C18 -
LB488 - Analysis of Sucralose -
LC InertSearch InertSustain C18 -
LB487 - Analysis of Verapamil Hydrochloride (Under the Condition of the Japanese Pharmacopoeia, Verapamil Hydrochloride Tablets) -
LC InertSearch InertSustain C18 -
LB485 - Analysis of Pyridoxal Phosphate Hydrate (Under the Condition of the Japanese Pharmacopoeia, (4) Related subatances) -
LC InertSearch InertSustain AQ-C18 -
LB484 - Analysis of Catecholamine metabolite -
LC InertSearch InertSustainSwift C18 -
LB483 - Analysis of Minocycline Hydrochloride (Under the Condition of the Japanese Pharmacopoeia 17th edition) -
LC InertSearch InertSustainSwift C8 -
LB480 - Analysis of 13 kinds of Aldehydes (Directed by Pre-Column Method with DNPH) -
LC InertSearch InertSustain C18 -
LB470 - Simultaneous analysis of Amino acids derivatized with 4-fluoro-7-nitro-2,1,3-benzoxadiazole (NBD-F) -
LC InertSearch InertSustainSwift C18 -
LB465 - Analysis of Fungicides -
LC InertSearch InertSustain C18 -
LB464 - Analysis of Ultraviolet absorbers -
LC InertSearch InertSustain C18 -
LB462 - Analysis of Cephalexin (Under the Condition of USP 39-NF34) -
LC InertSearch InertSustain C18 -
LB461 - Analysis of Phenylephrine Hydrochloride (Under the Condition of USP 39-NF34, Phenylephrine Hydrochloride Injection) -
LC InertSearch InertSustain C18 -
LB457 - Analysis of Hydroxynaphthoquinones -
LC InertSearch InertSustain C18 -
LB456 - Analysis of Benzenediols -
LC InertSearch InertSustain C18 -
LB455 - Analysis of Polar Peptides -
LC InertSearch InertSustain AQ-C18 -
LB452 - Analysis of Tranexamic acid(Under the Condition of the Japanese Pharmacopoeia, Tranexamic acid Tablets) -
LC InertSearch InertSustain AQ-C18 -
LB451 - Analysis of Tranexamic acid(Under the Condition of the Japanese Pharmacopoeia) -
LC InertSearch InertSustain AQ-C18 -
LB450 - Analysis of Tranexamic acid(Under the Condition of the Japanese Pharmacopoeia) -
LC InertSearch InertSustain AQ-C18 -
LB449 - Analysis of Lansoprazole(Under the Condition of the Japanese Pharmacopoeia) -
LC InertSearch InertSustain C18 -
LB448 - Analysis of Mesalazine(Under the Condition of the draft for the Japanese Pharmacopoeia, (8) 3-Aminophenol, 3-Aminobenzoic acid, Gentisic acid, Salicylic acid, other related substances and total related substance) -
LC InertSearch InertSustain C8 -
LB447 - Analysis of Mesalazine(Under the Condition of the draft for the Japanese Pharmacopoeia, (6) 2-Aminophenol and 4-Aminophenol) -
LC InertSearch InertSustainSwift C18 HP -
LB443 - Analysis of Nucleotide -
LC InertSearch InertSustain AQ-C18 -
LB441 - Analysis of Aflatoxin M1(InertSustain AQ-C18) -
LC InertSearch InertSustain AQ-C18 -
LB440 - Analysis of Myoglobin Digests (InertSustainSwift C18) -
LC InertSearch InertSustainSwift C18 -
LB439 - Analysis of Myoglobin Digests (InertSustain AQ-C18) -
LC InertSearch InertSustain AQ-C18 -
LB438 - Analysis of BSA Digests (InertSustainSwift C18) -
LC InertSearch InertSustainSwift C18 -
LB437 - Analysis of BSA Digests (InertSustain AQ-C18) -
LC InertSearch InertSustain AQ-C18 -
LB436 - Analysis of Mesalazine(Under the Condition of the Japanese Pharmacopoeia, (7) Aniline) -
LC InertSearch InertSustain C18 -
LB435 - Analysis of Povidone(Under the Condition of the Japanese Pharmacopoeia 17th edition, (6) 2-Pyrrolidone) -
LC InertSearch InertSustain AQ-C18 -
LB433 - Analysis of Povidone(Under the Condition of the Japanese Pharmacopoeia 17th edition, (4) 1-Vinyl-2-pyrrolidone) -
LC InertSearch InertSustain AQ-C18 -
LB430 - Analysis of Tulobuterol Hydrochloride(Under the Condition of the Japanese Pharmacopoeia 17th edition) -
LC InertSearch InertSustain C18 -
LB429 - Analysis of Tulobuterol(Under the Condition of the Japanese Pharmacopoeia 17th edition) -
LC InertSearch InertSustain C18 -
LB428 - Analysis of Zonisamide -
LC InertSearch InertSustain AQ-C18 -
LB427 - Analysis of Zonisamide -
LC InertSearch InertSustain AQ-C18 -
LB426 - Analysis of Diflorason Diacetate(Under the Condition of the Japanese Pharmacopoeia 17th edition) -
LC InertSearch InertSustain C18 -
LB425 - Analysis of Diflorason Diacetate(Under the Condition of the Japanese Pharmacopoeia 17th edition) -
LC InertSearch InertSustain C18 -
LB422 - Analysis of Nonsteroidal anti-inflammatory drug （InertSustain C18） -
LC InertSearch InertSustain C18 -
LB420 - Analysis of Acetaminophen (Under the Condition of the Japanese Pharmacopoeia) （InertSustainSwift C18） -
LC InertSearch InertSustainSwift C18 -
LB419 - Analysis of Acetaminophen (Under the Condition of the Japanese Pharmacopoeia) （InertSustain C18） -
LC InertSearch InertSustain C18 -
LB417 - Analysis of Vitamin K (InertSustainSwift C18) -
LC InertSearch InertSustainSwift C18 -
LB416 - Analysis of Vitamin K (InertSustain AQ-C18) -
LC InertSearch InertSustain AQ-C18 -
LB414 - Analysis of Esomeprazole magnesium (Under the Condition of USP 38-NF33, Esomeprazole magnesium Extended-release Tablets) -
LC InertSearch InertSustain C18 -
LB413 - Analysis of Eplerenone (Under the Condition of the draft for the Japanese Pharmacopoeia) -
LC InertSearch InertSustainSwift C18 -
LB412 - Analysis of Eplerenone (Under the Condition of the draft for the Japanese Pharmacopoeia) -
LC InertSearch InertSustainSwift C18 -
LB408 - Analysis of Fluconazole (Under the Condition of the Japanese Pharmacopoeia) -
LC InertSearch InertSustainSwift C18 -
LB406 - Analysis of Hippuric acid -
LC InertSearch InertSustain AQ-C18 HP -
LB405 - Analysis of Phenolic antioxidants -
LC InertSearch InertSustainSwift C18 -
LB402 - Analysis of Preservatives and Sweetener (InertSustain AQ-C18) -
LC InertSearch InertSustain AQ-C18 -
LB401 - Analysis of Preservatives and Sweetener (InertSustain AQ-C18) -
LC InertSearch InertSustain AQ-C18 -
LB400 - Analysis of 9 Drugs (InertSustain C18) -
LC InertSearch InertSustain C18 -
LB399 - Analysis of 9 Drugs (InertSustainSwift C18) -
LC InertSearch InertSustainSwift C18 -
LB398 - Analysis of 9 Drugs (InertSustain AQ-C18) -
LC InertSearch InertSustain AQ-C18 -
LB397 - Analysis of Glyphosate, Glufosinate and AMPA derivatized with 9-Fluorenylmethyl Chloroformate (FMOC) -
LC InertSearch InertSustainSwift C18 -
LB396 - Analysis of Oligonucleotide -
LC InertSearch InertSustainBio C18 -
LB395 - Analysis of Acetaminophen and Caffeine -
LC InertSearch InertSustainSwift C18 -
LB394 - Analysis of Methacrylic acid (InertSustain C18) -
LC InertSearch InertSustain C18 -
LB393 - Analysis of Methacrylic acid (InertSustainSwift C18) -
LC InertSearch InertSustainSwift C18 -
LB392 - Analysis of Methacrylic acid (InertSustain AQ-C18) -
LC InertSearch InertSustain AQ-C18 -
LB389 - Analysis of 12 Drugs (InertSustainSwift C18 HP) -
LC InertSearch InertSustainSwift C18 HP -
LB388 - Analysis of 12 Drugs (InertSustain C18 HP) -
LC InertSearch InertSustain C18 HP -
LB387 - Analysis of 12 Drugs (InertSustain AQ-C18 HP) -
LC InertSearch InertSustain AQ-C18 HP -
LB383 - Analysis of Angiotensin II receptor blockers (InertSustainSwift C18) -
LC InertSearch InertSustainSwift C18 -
LB382 - Analysis of Angiotensin II receptor blockers (InertSustain C18) -
LC InertSearch InertSustain C18 -
LB381 - Analysis of Angiotensin II receptor blockers (InertSustain AQ-C18) -
LC InertSearch InertSustain AQ-C18 -
LB380 - Analysis of ATP related compounds -
LC InertSearch InertSustain AQ-C18 -
LB378 - Analysis of Hippuric Acids -
LC InertSearch InertSustain AQ-C18 HP -
LB377 - Analysis of 13 kinds of Aldehydes (Directed by Pre-Column Method with DNPH) -
LC InertSearch InertSustain AQ-C18 HP -
LB375 - Analysis of Lidocaine -
LC InertSearch InertSustain C18 -
LB373 - Analysis of Cyclophosphamide (Under the Condition of the Japanese Pharmacopoeia, Cyclophosphamide Tablets) -
LC InertSearch InertSustainSwift C18 -
LB372 - Analysis of Cyclophosphamide (Under the Condition of the Japanese Pharmacopoeia, Cyclophosphamide Tablets) -
LC InertSearch InertSustainSwift C18 -
LB371 - Analysis of Amlodipine besilate (Under the Condition of the Japanese Pharmacopoeia, Amlodipine Besilate Orally Disintegrating Tablets) -
LC InertSearch InertSustainSwift C18 -
LB368 - Analysis of Nucleoside and Nucleic acid base (InertSustain C18) -
LC InertSearch InertSustain C18 -
LB367 - Analysis of Nucleoside and Nucleic acid base (InertSustain C18) -
LC InertSearch InertSustain C18 -
LB366 - Analysis of Nucleoside and Nucleic acid base (InertSustain AQ-C18) -
LC InertSearch InertSustain AQ-C18 -
LB365 - Analysis of Nucleoside and Nucleic acid base (InertSustain AQ-C18) -
LC InertSearch InertSustain AQ-C18 -
LB364 - Analysis of Water-soluble Vitamins -
LC InertSearch InertSustain AQ-C18 -
LB363 - Analysis of Organic acid -
LC InertSearch InertSustain AQ-C18 -
LB362 - Analysis of β-blocker -
LC InertSearch InertSustain AQ-C18 -
LB361 - Analysis of Furfral and 5-Hydroxymethylfurfral (InertSustain AQ-C18) -
LC InertSearch InertSustain AQ-C18 -
LB360 - Analysis of Roxithromycin (Under the Condition of the Japanese Pharmacopoeia, Roxithromycin Tablets) -
LC InertSearch InertSustain C18 -
LB359 - Analysis of EPA and DHA -
LC InertSearch InertSustain C18 -
LB358 - Analysis of EPA and DHA (InertSustain C18) -
LC InertSearch InertSustain C18 -
LB355 - Analysis of 7 fatty acids -
LC InertSearch InertSustain C18 -
LB354 - Analysis of 7 fatty acids -
LC InertSearch InertSustain C18 -
LB353 - Analysis of 7 fatty acids -
LC InertSearch InertSustain C18 -
LB352 - Analysis of 7 fatty acids (InertSustain C18) -
LC InertSearch InertSustain C18 -
LB349 - Analysis of Sodium Propionate (InertSustain C18) -
LC InertSearch InertSustain C18 -
LB342 - Analysis of Furfral and 5-Hydroxymethylfurfral (InertSustainSwift C18) -
LC InertSearch InertSustainSwift C18 -
LB341 - Analysis of Furfral and 5-Hydroxymethylfurfral (InertSustain C18) -
LC InertSearch InertSustain C18 -
LB340 - Analysis of Chelating compounds -
LC InertSearch InertSustain C18 -
LB339 - Analysis of Rebamipide (Under the Condition of the Japanese Pharmacopoeia, Rebamipide Tablets) -
LC InertSearch InertSustain C18 -
LB337 - Analysis of Glyphosate, Glufosinate and AMPA derivatized with 9-Fluorenylmethyl Chloroformate (FMOC) -
LC InertSearch InertSustain C18 -
LB330 - Analysis of Roxithromycin (Under the Condition of the Japanese Pharmacopoeia) -
LC InertSearch InertSustain C18 -
LB318 - Analysis of Maleic acid, Fumaric acid and Acrylic acid (InertSustainSwift C18) -
LC InertSearch InertSustainSwift C18 -
LB314 - Analysis of Acesulfame potassium (InertSustain C18) (Under the Condition of the JSFA-VIII (Japanese Standards of Food Additives)) -
LC InertSearch InertSustain C18 -
LB312 - Analysis of Acesulfame potassium (InertSustain C18) (Under the Condition of the JPE (Japanese Pharmaceutical Excipients)) -
LC InertSearch InertSustain C18 -
LB291 - Analysis of Ticlopidine hydrochloride (Under the Condition of the Japanese Pharmacopoeia, Ticlopidine hydrochloride Tablets) -
LC InertSearch InertSustain C18 -
LB290 - Analysis of Cefalexin (Under the Condition of the Japanese Pharmacopoeia, Cefalexin Combination Granules) -
LC InertSearch InertSustain C18 -
LB284 - Analysis of Silodosin (Under the Condition of the Japanese Pharmacopoeia) -
LC InertSearch InertSustain C18 -
LB283 - Analysis of Silodosin (Under the Condition of the Japanese Pharmacopoeia) -
LC InertSearch InertSustain C18 -
LB271 - Analysis of Tulathromycin -
LC InertSearch InertSustainSwift C18 -
LB270 - Analysis of β-blocker -
LC InertSearch InertSustainSwift C18 -
LB269 - Analysis of Tetracyclines (InertSustainSwift C18) -
LC InertSearch InertSustainSwift C18 -
LB268 - Analysis of Tetracyclines (InertSustain C18) -
LC InertSearch InertSustain C18 -
LB260 - Analysis of Chlorophenol -
LC InertSearch InertSustain C18 HP -
LB256 - Analysis of Nucleobase (InertSustain C18) -
LC InertSearch InertSustain C18 -
LB253 - Analysis of Tranilast (Under the Condition of the Japanese Pharmacopoeia, Tranilast Capsules) -
LC InertSearch InertSustain C18 -
LB247 - Analysis of Terbinafine hydrochloride (Under the Condition of the Japanese Pharmacopoeia, Terbinafine hydrochloride Cream) -
LC InertSearch InertSustainSwift C18 -
LB241 - Analysis of Preservatives and Sweetener (InertSustain C18) -
LC InertSearch InertSustain C18 -
LB239 - Analysis of Preservatives and Sweetener (InertSustainSwift C18) -
LC InertSearch InertSustainSwift C18 -
LB237 - Analysis of Preservatives and Sweetener (InertSustain C18) -
LC InertSearch InertSustain C18 -
LB236 - Analysis of Preservatives and Sweetener (InertSustainSwift C18) -
LC InertSearch InertSustainSwift C18 -
LB234 - Analysis of Amino acids -
LC InertSearch InertSustainSwift C18 -
LB233 - Analysis of Amino acids -
LC InertSearch InertSustainSwift C18 -
LB232 - Analysis of Leuprorelin acetate (Under the Condition of the Japanese Pharmacopoeia) -
LC InertSearch InertSustainSwift C18 HP -
LB231 - Analysis of Leuprorelin acetate (Under the Condition of the Japanese Pharmacopoeia) -
LC InertSearch InertSustainSwift C18 HP -
LB230 - Analysis of Leuprorelin acetate (Under the Condition of the Japanese Pharmacopoeia) -
LC InertSearch InertSustainSwift C18 HP -
LB228 - Analysis of Polyvinyl alcohol, Polyethyleneglycol and Graft copolymer (Under the Condition of the JPE (Japanese Pharmaceutical Excipients), (3) Acetic acid) -
LC InertSearch InertSustain C18 -
LB224 - Analysis of Tocopherol (InertSuatin C18) (Under the Condition of the Japanese Pharmaceutical Codex) -
LC InertSearch InertSustain C18 -
LB222 - Analysis of Butenafine hydrochloride (Under the Condition of the Japanese Pharmacopoeia) -
LC InertSearch InertSustain C18 HP -
LB211 - Analysis of 2 kinds of Aldehydes (InertSustain C18) (Directed by Pre-Column Method with DNPH) -
LC InertSearch InertSustain C18 -
LB210 - Analysis of Pioglitazone hydrochloride (Under the Condition of the Japanese Pharmacopoeia) -
LC InertSearch InertSustain C18 -
LB209 - Analysis of Pioglitazone hydrochloride (Under the Condition of the Japanese Pharmacopoeia) -
LC InertSearch InertSustain C18 -
LB204 - Analysis of Metformin hydrochloride (Under the Condition of the Japanese Pharmacopoeia, Metformin hydrochloride Tablets) -
LC InertSearch InertSustain C18 -
LB196 - Analysis of Ciprofloxacin hydrochloride (Under the Condition of the Japanese Pharmacopoeia, Ciprofloxacin hydrochloride hydrate) -
LC InertSearch InertSustain C18 -
LB187 - Analysis of Chlorpheniramine maleate (Under the Condition of the Japanese Pharmacopoeia,Chlorpheniramine maleate Tablets) -
LC InertSearch InertSustain C18 -
LB186 - Analysis of Chlorpheniramine maleate (Under the Condition of the Japanese Pharmacopoeia,Chlorpheniramine maleate Tablets) -
LC InertSearch InertSustain C18 -
LB185 - Analysis of Chlorpheniramine maleate (Under the Condition of the Japanese Pharmacopoeia,Chlorpheniramine maleate Tablets) -
LC InertSearch InertSustain C18 -
LB183 - Analysis of Phellodendron Bark (InertSustain C18) (Under the Condition of the Japanese Pharmacopoeia) -
LC InertSearch InertSustain C18 -
LB182 - Analysis of Glycyrrhiza (Under the Condition of the Japanese Pharmacopoeia) -
LC InertSearch InertSustain C18 -
LB181 - Analysis of Glycyrrhiza (Under the Condition of the Japanese Pharmacopoeia) -
LC InertSearch InertSustain C18 -
LB177 - Analysis of Povidone (Under the Condition of the draft for the Japanese Pharmacopoeia, (8) 2-pyrrolidone) -
LC InertSearch InertSustain C18 -
LB176 - Analysis of Povidone (Under the Condition of the draft for the Japanese Pharmacopoeia, (4) 1-Vinyl-2-pyrrolidone) -
LC InertSearch InertSustain C18 -
LB175 - Analysis of Loxoprofen (Under the Condition of the Japanese Pharmacopoeia, Loxoprofen sodium Tablets) -
LC InertSearch InertSustain C18 -
LB173 - Analysis of Azelastine hydrochloride (Under the Condition of the Japanese Pharmacopoeia) -
LC InertSearch InertSustain C18 -
LB167 - Analysis of Crospovidone (Under the Condition of the Japanese Pharmacopoeia) -
LC InertSearch InertSustain C18 -
LB159 - Analysis of Clopidogrel sulfate (InertSustain C18) (Under the Condition of the Japanese Pharmacopoeia) -
LC InertSearch InertSustain C18 -
LB157 - Analysis of Clopidogrel sulfate (InertSustain C18) (Under the Condition of the Japanese Pharmacopoeia) -
LC InertSearch InertSustain C18 -
LB151 - Analysis of Liner alkylbenzene sulfonate (InertSustain C18 HP) -
LC InertSearch InertSustain C18 HP -
LB149 - Analysis of Liner alkylbenzene sulfonate (InertSustain C18 HP) -
LC InertSearch InertSustain C18 HP -
LB130 - Analysis of Amantadine (InertSustain C18) -
LC InertSearch InertSustain C18 -
LB114 - Analysis of Epalrestat (Under the Condition of the Japanese Pharmacopoeia) -
LC InertSearch InertSustain C18 -
LB113 - Analysis of Epalrestat (Under the Condition of the Japanese Pharmacopoeia) -
LC InertSearch InertSustain C18 -
LB112 - Analysis of Sivelestat sodium hydrate (Under the Condition of the Japanese Pharmacopoeia) -
LC InertSearch InertSustain C18 -
LB111 - Analysis of Sivelestat sodium hydrate (Under the Condition of the Japanese Pharmacopoeia) -
LC InertSearch InertSustain C18 -
LB109 - Analysis of Organic acids (InertSustain C18) -
LC InertSearch InertSustain C18 -
LB107 - Analysis of Pre-column Derivatized Aflatoxin -
LC InertSearch InertSustain C18 -
LB087 - Analysis of Naftopidil (Under the Condition of the Japanese Pharmacopoeia, Naftopidil Tablets) -
LC InertSearch InertSustain C18 -
LB086 - Analysis of Naftopidil (Under the Condition of the Japanese Pharmacopoeia) -
LC InertSearch InertSustain C18 -
LB084 - Analysis of Olmesartan medoxomil (Under the Condition of United States Pharmacopeia 35-NF30) -
LC InertSearch InertSustain C18 -
LB076 - Analysis of 4 Pesticides (InertSustain C18) -
LC InertSearch InertSustain C18 -
LB075 - Analysis of Venlafaxine (InertSustain C18) -
LC InertSearch InertSustain C18 -
LB074 - Analysis of Rabeprazol (InertSustain C18) -
LC InertSearch InertSustain C18 -
LB071 - Analysis of Esomeprazol (InertSustain C18) -
LC InertSearch InertSustain C18 -
LB070 - Analysis of 13 drugs for NSAIDs -
LC InertSearch InertSustain C18 -
LB069 - Analysis of Rosuvastatin Calcium -
LC InertSearch InertSustain C18 -
LB068 - Analysis of Olmesartan medoxomil -
LC InertSearch InertSustain C18 -
LB067 - Analysis of Aripiprazole -
LC InertSearch InertSustain C18 -
LB066 - Analysis of Mosapride Citrate Tablets (Under the Condition of Japanese Pharmacopoeia 16) -
LC InertSearch InertSustain C18 -
LB063 - Analysis of Tranilast (InertSustain C18)(Under the Condition of the Japanese Pharmacopoeia) -
LC InertSearch InertSustain C18 -
LB058 - Analysis of Amlodipine Besilate (Under the Condition of Japanese Pharmacopoeia, Amlodipine Besilate Tablets) -
LC InertSearch InertSustain C18 -
LB042 - Analysis of 18Drugs(InertSustain C18 2um) -
LC InertSearch InertSustain C18 -
LB039 - Analysis of Phospholipids (InertSustain C18) -
LC InertSearch InertSustain C18 -
LB038 - Analysis of Chlorantraniliprole (InertSustain C18) -
LC InertSearch InertSustain C18 -
LB035 - Analysis of Terbinafine HCl (InertSustain C18) (Under the Condition of Japanese Pharmacopoeia) -
LC InertSearch InertSustain C18 -
LB029 - Analysis of Pitavastatin Calcium -
LC InertSearch InertSustain C18 -
LB028 - Analysis of Pitavastatin Calcium -
LC InertSearch InertSustain C18 -
LB027 - Analysis of Pitavastatin Calcium -
LC InertSearch InertSustain C18 -
LB026 - Analysis of Pitavastatin Calcium -
LC InertSearch InertSustain C18 -
LB025 - Analysis of Atorvastatin Calcium (Under the Condition of Japanese Pharmacopoeia, Atorvastatin Calcium Hydrate) -
LC InertSearch InertSustain C18 -
LB024 - Analysis of Atorvastatin Calcium (Under the Condition of Japanese Pharmacopoeia, Atorvastatin Calcium Tablets) -
LC InertSearch InertSustain C18 -
LB023 - Analysis of Atorvastatin Calcium (Under the Condition of Japanese Pharmacopoeia, Atorvastatin Calcium Tablets) -
LC InertSearch InertSustain C18 -
LB022 - Analysis of Losartan potassium and Valsartan -
LC InertSearch InertSustain C18 -
LB021 - Analysis of Valsartan and Hydrochlorothiazide -
LC InertSearch InertSustain C18 -
LB018 - Analysis of Potassium ferricyanide and Potassium ferrocyanide -
LC InertSearch InertSustain C18 -
LB016 - Analysis of Iminoctadine -
LC InertSearch InertSustain C18 -
LB014 - Analysis of Ergosterol(InertSustain C18) -
LC InertSearch InertSustain C18 -
LB013 - Analysis of Iohexol and Iopamidol -
LC InertSearch InertSustain C18 -
LA998 - Analysis of 5 kinds of Aldehydes (Directed by Pre-Column Method with DNPH) -
LC InertSearch InertSustain C18 -
LA997 - Analysis of 5 kinds of Aldehydes (Directed by Pre-Column Method with DNPH) -
LC InertSearch InertSustain C18 -
LA995 - Analysis of Fexofenadine hydrochloride (InertSustain C18) -
LC InertSearch InertSustain C18 -
LA992 - Analysis of Spiramycins in Beef -
LC InertSearch InertSustain C18 -
LA991 - Analysis of Spiramycins -
LC InertSearch InertSustain C18 -
LA985 - Analysis of Proteins (InertSustain C18) -
LC InertSearch InertSustain C18 -
LA981 - Analysis of 5-Aminoisophthalic acid -
LC InertSearch InertSustain C18 -
LA980 - Analysis of Oxine-copper -
LC InertSearch InertSustain C18 -
LA978 - Analysis of Tolcloｆos-methyl -
LC InertSearch InertSustain C18 -
LA977 - Analysis of Recerpine (InertSustain C18) -
LC InertSearch InertSustain C18 -
LA973 - Analysis of Non-ionic surfactant(Detected by Pre-Column complexation with Co-PAR) -
LC InertSearch InertSustain C18 -
LA972 - Analysis of Loxoprofen- InertSustain C18(Under the Condition of Japanese Pharmacopoeia) -
LC InertSearch InertSustain C18 -
LA969 - Analysis of Antioxidant(BHT) -
LC InertSearch InertSustain C18 -
LA966 - Analysis of Valsartan (InertSustain C18) -
LC InertSearch InertSustain C18 -
LA965 - Analysis of DNPH Aldehydes(Detected by Pre-Column Method with DNPH) -
LC InertSearch InertSustain C18 -
LA964 - Analysis of DNPH Aldehydes(Detected by Pre-Column Method with DNPH) -
LC InertSearch InertSustain C18 -
LA962 - Analysis of 13 kinds of Aldehydes(Detected by Pre-Column Method with DNPH) -
LC InertSearch InertSustain C18 -
LA961 - Analysis of 13 kinds of Aldehydes(Detected by Pre-Column Method with DNPH) -
LC InertSearch InertSustain C18 -
LA960 - Analysis of 13 kinds of Aldehydes(Detected by Pre-Column Method with DNPH) -
LC InertSearch InertSustain C18 -
LA959 - Analysis of 13 kinds of Aldehydes(Detected by Pre-Column Method with DNPH) -
LC InertSearch InertSustain C18 -
LA958 - Analysis of 13 kinds of Aldehydes(Detected by Pre-Column Method with DNPH) -
LC InertSearch InertSustain C18 -
LA956 - Analysis of Glutathione HPLC-ECD -
LC InertSearch InertSustain C18 -
LA955 - Analysis of Parabens (InertSustain C18) -
LC InertSearch InertSustain C18 -
LA952 - Analysis of Parabens (InertSustain C18) -
LC InertSearch InertSustain C18 -
LA949 - Analysis of Histamine and Thiamne (InertSustain C18) -
LC InertSearch InertSustain C18 -
LA947 - Analysis of Parabens (InertSustain C18) -
LC InertSearch InertSustain C18 -
LA943 - Analysis of Azithromycin -
LC InertSearch InertSustain C18 -
LA935 - Analysis of Alcohols HPLC-ECD -
LC InertSearch InertSustain C18 -
LA934 - Analysis of Diquat and Paraquat -
LC InertSearch InertSustain C18 -
LA930 - Analysis of Cold medicine (InertSustain C18) -
LC InertSearch InertSustain C18 -
LA929 - Analysis of Acetylsalicylic acid (InertSustain C18) -
LC InertSearch InertSustain C18 -
LA920 - Analysis of Levofolinate calcium -
LC InertSearch InertSustain C18 -
LA919 - Analysis of Levofolinate calcium -
LC InertSearch InertSustain C18 -
LA918 - Analysis of carbamate insecticides - Inertsil ODS-4(Ditected by post-column method with OPA) -
LC InertSearch Inertsil ODS-4 -
LA917 - Analysis of carbamate insecticides - Inertsil ODS-3(Ditected by post-column method with OPA) -
LC InertSearch Inertsil ODS-3 -
LA916 - Analysis of carbamate insecticides - InertSustain C18(Ditected by post-column method with OPA) -
LC InertSearch InertSustain C18 -
LA915 - Analysis of carbamate insecticides - InertSustain C18(Ditected by post-column method with OPA) -
LC InertSearch InertSustain C18 -
LA914 - Analysis of Carbamate insecticides - InertSustain C18(Directed by Post-Column Method with OPA) -
LC InertSearch InertSustain C18 -
LA913 - Analysis of 9 kinds of Pesticides for Golf Course(InertSustain C18) -
LC InertSearch InertSustain C18 -
LA912 - Analysis of 9 kinds of Pesticides for Golf Course(InertSustain C18) -
LC InertSearch InertSustain C18 -
LA910 - Analysis of 13 kinds of Aldehydes(Detected by Pre-Column Method with DNPH) -
LC InertSearch InertSustain C18 -
LA909 - Analysis of Indometacin (InertSustain C18) -
LC InertSearch InertSustain C18 -
LA906 - Analysis of Licorice extract (InertSustain C18) -
LC InertSearch InertSustain C18 -
LA905 - Analysis of Glycyrrhiza Standard (InertSustain C18) -
LC InertSearch InertSustain C18 -
LA904 - Analysis of Bilberry extract (InertSustain C18) -
LC InertSearch InertSustain C18 -
LA903 - Analysis of Basic drugs (InertSustain C18) -
LC InertSearch InertSustain C18 -
LA902 - Analysis of Basic drugs (InertSustain C18) -
LC InertSearch InertSustain C18 -
LA895 - Analysis of Nucleoside and Nucleic acid base (InertSustain C18) -
LC InertSearch InertSustain C18 -
LA893 - Analysis of Fat-soluble Vitamins (InertSustain C18) -
LC InertSearch InertSustain C18 -
LA892 - Analysis of Vitamin K (InertSustain C18) -
LC InertSearch InertSustain C18 -
LA891 - Analysis of Phytosterol (InertSustain C18) -
LC InertSearch InertSustain C18 HP -
LA890 - Analysis of Basic Drugs (InertSustain C18) -
LC InertSearch InertSustain C18 HP -
LA889 - Analysis of Basic Drugs (InertSustain C18) -
LC InertSearch InertSustain C18 HP -
LA522 - Analysis of Resveratrol -
LC InertSearch InertSustain C18